Cargando…

New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications

Detalles Bibliográficos
Autores principales:	Abdool Karim, Salim S., de Oliveira, Tulio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008749/ https://www.ncbi.nlm.nih.gov/pubmed/33761203 http://dx.doi.org/10.1056/NEJMc2100362

Ejemplares similares

Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection
por: Karim, Salim S Abdool
Publicado: (2021)

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
por: Karim, Salim S Abdool, et al.
Publicado: (2021)

Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives
por: Baxter, Cheryl, et al.
Publicado: (2021)

Implications of COVID-19 vaccine boosters amid the emergence of novel variants of SARS-CoV-2
por: Dhawan, Manish, et al.
Publicado: (2022)

Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
por: Uriu, Keiya, et al.
Publicado: (2021)

Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons
por: Kissler, Stephen M., et al.
Publicado: (2021)

SARS-CoV-2 variants and ending the COVID-19 pandemic
por: Fontanet, Arnaud, et al.
Publicado: (2021)

Hybrid SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2022)

Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant
por: Zhang, Wei, et al.
Publicado: (2022)

SARS CoV2 vaccine and aphasia
por: sookaromdee, Pathum, et al.
Publicado: (2021)

Potential implications of SARS-CoV-2 on pregnancy
por: Tseng, Jen-Yu
Publicado: (2020)

Vaccine inequity and hesitancy: Dual factors in the emergence of novel SARS-CoV-2 variants
por: Dhawan, Manish, et al.
Publicado: (2021)

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons
por: Rössler, Annika, et al.
Publicado: (2022)

Increased immune escape of the new SARS-CoV-2 variant of concern Omicron
por: Hu, Jie, et al.
Publicado: (2022)

A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice
por: Zhang, Rong, et al.
Publicado: (2022)

Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization
por: Wang, Guo-Lin, et al.
Publicado: (2021)

The impact of SARS-CoV-2 variants on IBD management
por: Segal, Jonathan P, et al.
Publicado: (2021)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Where is the next SARS-CoV-2 variant of concern?
por: Dennehy, John J, et al.
Publicado: (2022)

SARS-CoV-2 incidence and vaccine escape
por: Thompson, Robin N, et al.
Publicado: (2021)

Effect of Vaccination on Transmission of SARS-CoV-2
por: Shah, Anoop S.V., et al.
Publicado: (2021)

Hemophagocytic lymphohistiocytosis and SARS-CoV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Post SARS-CoV-2 vaccination effluvium
por: Luu, Ngoc-Nhi C., et al.
Publicado: (2023)

Field evaluations of four SARS-CoV-2 rapid antigen tests during SARS-CoV-2 Delta variant wave in South Africa
por: Samsunder, Natasha, et al.
Publicado: (2023)

Rapid genome sequencing in hospitals to identify potential vaccine-escape SARS-CoV-2 variants
por: Snell, Luke B, et al.
Publicado: (2021)

Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination
por: Yu, Xiaoqi, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
por: Pajon, Rolando, et al.
Publicado: (2022)

Surveillance of SARS-CoV-2 in Zimbabwe shows dominance of variants of concern
por: Mashe, Tapfumanei, et al.
Publicado: (2021)

An action plan for pan-European defence against new SARS-CoV-2 variants
por: Priesemann, Viola, et al.
Publicado: (2021)

Detection of SARS-CoV-2 infections in passengers arriving from China and their implications on air travel and public health in Italy
por: Sah, Ranjit, et al.
Publicado: (2023)

SARS-CoV-2 new variant BF.7: a new public threat globally, symptoms, precautions, transmission rate, and futures perspective – correspondence
por: Rahman, Md. Mominur, et al.
Publicado: (2023)

Rapid identification and tracking of SARS-CoV-2 variants of concern
por: Chakraborty, Debojyoti, et al.
Publicado: (2021)

Hospitalisation associated with SARS-CoV-2 delta variant in Denmark
por: Bager, Peter, et al.
Publicado: (2021)

SARS-CoV-2 rapid diagnostic tests for emerging variants
por: Bekliz, Meriem, et al.
Publicado: (2021)

Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants
por: Evans, John P., et al.
Publicado: (2022)

SARS-CoV-2 Variants and Multisystem Inflammatory Syndrome in Children
por: McCrindle, Brian W., et al.
Publicado: (2023)

T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals
por: Jordan, Stanley C., et al.
Publicado: (2021)

Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
por: Edara, Venkata-Viswanadh, et al.
Publicado: (2021)

More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants
por: Monach, Paul A, et al.
Publicado: (2023)

Broad neutralization against SARS-CoV-2 variants induced by a next-generation protein vaccine V-01
por: Sun, Shiyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jq1lrdsjtaljvrij7jn64uhijr